Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability

Authors

  • Philippe Halfon,

    1. Laboratoire Alphabio, Hôpital Ambroise Paré Marseille, France
    Search for more papers by this author
  • Michelle Martinot-Peignoux,

    1. Institut National de la Santé et de la Recherche Médicale, U-773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3 and Service d'Hépatologie, Hôpital Beaujon, Université Paris 7, Clichy, France
    Search for more papers by this author
  • Hacène Khiri,

    1. Laboratoire Alphabio, Hôpital Ambroise Paré Marseille, France
    Search for more papers by this author
  • Patrick Marcellin

    1. Institut National de la Santé et de la Recherche Médicale, U-773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3 and Service d'Hépatologie, Hôpital Beaujon, Université Paris 7, Clichy, France
    Search for more papers by this author

  • Potential conflict of interest: Dr. Marcellin received grants, is on the speakers' bureau of, and advises Roche, Schering-Plough, and Gilead. He also advises and is on the speakers' bureau of Bristol-Myers Squibb, Novartis, and Intermune. He advises Vertex, Pharmaseet, Tibotec, Merck Sharp & Dohme, Boehringer, Biolex, and Zymogenetics.

No abstract is available for this article.

Ancillary